A citation-based method for searching scientific literature

Fatemeh Khatami, Seyed Mohammad Tavangar. Iran J Pathol 2018
Times Cited: 9







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
44

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
33


Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong,[...]. Lancet 2014
877
33

The Cancer Genome Atlas Pan-Cancer analysis project.
John N Weinstein, Eric A Collisson, Gordon B Mills, Kenna R Mills Shaw, Brad A Ozenberger, Kyle Ellrott, Ilya Shmulevich, Chris Sander, Joshua M Stuart. Nat Genet 2013
22

Cancer treatment and survivorship statistics, 2016.
Kimberly D Miller, Rebecca L Siegel, Chun Chieh Lin, Angela B Mariotto, Joan L Kramer, Julia H Rowland, Kevin D Stein, Rick Alteri, Ahmedin Jemal. CA Cancer J Clin 2016
22


Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
22

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Nikhil Gupta, Anil K Dasyam, Sally E Carty, Marina N Nikiforova, N Paul Ohori, Michaele Armstrong, Linwah Yip, Shane O LeBeau, Kelly L McCoy, Christopher Coyne,[...]. J Clin Endocrinol Metab 2013
101
22

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
431
22

Gene Fusions in Thyroid Cancer.
Valentina D Yakushina, Larisa V Lerner, Alexander V Lavrov. Thyroid 2018
56
22

Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.
Hiva Saffar, Sanaz Sanii, Binesh Emami, Ramin Heshmat, Vahid Hagh Panah, Sima Azimi, Seyed Mohammad Tavangar. Pathol Res Pract 2013
18
22

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.
Cristina Romei, Rossella Elisei. Front Endocrinol (Lausanne) 2012
85
22

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, Eric J Sherman. Lancet Oncol 2016
186
22

Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma.
C Pupilli, P Pinzani, F Salvianti, B Fibbi, M Rossi, L Petrone, G Perigli, M L De Feo, V Vezzosi, M Pazzagli,[...]. J Clin Endocrinol Metab 2013
40
22

Liquid Biopsy in Thyroid Cancer: New Insight.
Fatemeh Khatami, Seyed Mohammad Tavangar. Int J Hematol Oncol Stem Cell Res 2018
25
22

Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
Priyadarshini Raman, Ronald J Koenig. Nat Rev Endocrinol 2014
74
22

RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
111
22



BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
951
22


TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
206
22

The prevalence and prognostic value of BRAF mutation in thyroid cancer.
Electron Kebebew, Julie Weng, Juergen Bauer, Gustavo Ranvier, Orlo H Clark, Quan-Yang Duh, Daniel Shibru, Boris Bastian, Ann Griffin. Ann Surg 2007
336
22

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, YiYu Dong, Ed Reznik, Venkatraman Seshan, Gouri Nanjangud, Stephanie Eng, Promita Bose, Fengshen Kuo,[...]. Cancer Cell 2018
121
22

Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Hans-Juergen Schulten, Sherine Salama, Alaa Al-Ahmadi, Zuhoor Al-Mansouri, Zeenat Mirza, Khalid Al-Ghamdi, Osman Abdel Al-Hamour, Etimad Huwait, Mamdooh Gari, Mohammad Hussain Al-Qahtani,[...]. Anticancer Res 2013
30
22

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma,[...]. Genes (Basel) 2019
52
22

Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
Xingkai Liu, Chang Su, Jing Xu, Dan Zhou, He Yan, Wei Li, Guihui Chen, Nan Zhang, Dahai Xu, Haixia Hu. Oncol Lett 2019
8
25

Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease.
Eman A Toraih, Mohammad H Hussein, Mourad Zerfaoui, Abdallah S Attia, Assem Marzouk Ellythy, Arwa Mostafa, Emmanuelle M L Ruiz, Mohamed Ahmed Shama, Jonathon O Russell, Gregory W Randolph,[...]. Cancers (Basel) 2021
12
22

Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling.
Swati Tomar, Raman Sethi, Gangadhara Sundar, Thuan Chong Quah, Boon Long Quah, Poh San Lai. PLoS One 2017
29
11

A linear complexity phasing method for thousands of genomes.
Olivier Delaneau, Jonathan Marchini, Jean-François Zagury. Nat Methods 2011
11

Effect of read-mapping biases on detecting allele-specific expression from RNA-sequencing data.
Jacob F Degner, John C Marioni, Athma A Pai, Joseph K Pickrell, Everlyne Nkadori, Yoav Gilad, Jonathan K Pritchard. Bioinformatics 2009
331
11


Cancer genes and the pathways they control.
Bert Vogelstein, Kenneth W Kinzler. Nat Med 2004
11

Entrez Gene: gene-centered information at NCBI.
Donna Maglott, Jim Ostell, Kim D Pruitt, Tatiana Tatusova. Nucleic Acids Res 2011
512
11

Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
Rachael A Hancox, Michael D Allen, Deborah L Holliday, Dylan R Edwards, Caroline J Pennington, David S Guttery, Jacqueline A Shaw, Rosemary A Walker, J Howard Pringle, J Louise Jones. Breast Cancer Res 2009
85
11

DNA methylation represses transcription in vivo.
Z Siegfried, S Eden, M Mendelsohn, X Feng, B Z Tsuberi, H Cedar. Nat Genet 1999
267
11

Transcriptome and genome sequencing uncovers functional variation in humans.
Tuuli Lappalainen, Michael Sammeth, Marc R Friedländer, Peter A C 't Hoen, Jean Monlong, Manuel A Rivas, Mar Gonzàlez-Porta, Natalja Kurbatova, Thasso Griebel, Pedro G Ferreira,[...]. Nature 2013
11


Systematic Analysis of Splice-Site-Creating Mutations in Cancer.
Reyka G Jayasinghe, Song Cao, Qingsong Gao, Michael C Wendl, Nam Sy Vo, Sheila M Reynolds, Yanyan Zhao, Héctor Climente-González, Shengjie Chai, Fang Wang,[...]. Cell Rep 2018
127
11

Splice-switching antisense oligonucleotides as therapeutic drugs.
Mallory A Havens, Michelle L Hastings. Nucleic Acids Res 2016
224
11

Mapping Bias Overestimates Reference Allele Frequencies at the HLA Genes in the 1000 Genomes Project Phase I Data.
Débora Y C Brandt, Vitor R C Aguiar, Bárbara D Bitarello, Kelly Nunes, Jérôme Goudet, Diogo Meyer. G3 (Bethesda) 2015
82
11

Involvement of large tenascin-C splice variants in breast cancer progression.
Takatsugu Tsunoda, Hiroyasu Inada, Ilunga Kalembeyi, Kyoko Imanaka-Yoshida, Mirei Sakakibara, Ray Okada, Koji Katsuta, Teruyo Sakakura, Yuichi Majima, Toshimichi Yoshida. Am J Pathol 2003
92
11

cisASE: a likelihood-based method for detecting putative cis-regulated allele-specific expression in RNA sequencing data.
Zhi Liu, Tuantuan Gui, Zhen Wang, Hong Li, Yunhe Fu, Xiao Dong, Yixue Li. Bioinformatics 2016
6
16

Aberrant RNA Splicing in Cancer.
Luisa Escobar-Hoyos, Katherine Knorr, Omar Abdel-Wahab. Annu Rev Cancer Biol 2019
41
11

A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.
Yiqun Zhang, Lixing Yang, Melanie Kucherlapati, Fengju Chen, Angela Hadjipanayis, Angeliki Pantazi, Christopher A Bristow, Eunjung A Lee, Harshad S Mahadeshwar, Jiabin Tang,[...]. Cell Rep 2018
49
11


Allele-specific expression and eQTL analysis in mouse adipose tissue.
Yehudit Hasin-Brumshtein, Farhad Hormozdiari, Lisa Martin, Atila van Nas, Eleazar Eskin, Aldons J Lusis, Thomas A Drake. BMC Genomics 2014
35
11

Large differences in global transcriptional regulatory programs of normal and tumor colon cells.
David Cordero, Xavier Solé, Marta Crous-Bou, Rebeca Sanz-Pamplona, Laia Paré-Brunet, Elisabet Guinó, David Olivares, Antonio Berenguer, Cristina Santos, Ramón Salazar,[...]. BMC Cancer 2014
24
11

Early references to the mutational origin of cancer.
Volker Wunderlich. Int J Epidemiol 2007
15
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.